title: When to consider an implantable cardioverter defibrillator following myocardial infarction?
abstract: After reading this article the reader should be familiar with: Current guidelines for implantable cardioverter defibrillator (ICD) use post myocardial infarction (MI) and ischaemic cardiomyopathy. Primary prevention ICD guidelines. Secondary prevention ICD guidelines. Non-sustained ventricular tachycardia in patients post MI and the use of ICDs. Programming ICDs.
authors.affiliation: Department of Cardiology, Ninewells Hospital and Medical School, Dundee, UK.
authors.forename: Benjamin R
authors.initials: BR
authors.lastname: Szwejkowski
authors.affiliation: Department of Cardiology, Golden Jubilee National Hospital, Clydebank, UK.
authors.forename: Gary A
authors.initials: GA
authors.lastname: Wright
authors.affiliation: Department of Cardiology, Golden Jubilee National Hospital, Clydebank, UK.
authors.forename: Derek T
authors.initials: DT
authors.lastname: Connelly
authors.affiliation: Department of Cardiology, Golden Jubilee National Hospital, Clydebank, UK.
authors.forename: Roy S
authors.initials: RS
authors.lastname: Gardner
mesh_terms: D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000209:etiology / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D018579:Patient Selection; D011322:Primary Prevention / Q000295:instrumentation*; D011474:Prosthesis Design; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D055502:Secondary Prevention / Q000295:instrumentation*; D013318:Stroke Volume; D013997:Time Factors; D061665:Time-to-Treatment; D016896:Treatment Outcome; D016277:Ventricular Function, Left